In the marker genome, downregulation of SNAP25 was clearly involved in cancer pathways, prostate cancer, and the WNT, TGF-β, and MAPK signaling pathways (Fig. 9a–e). The gene discussed is SNAP25; the disease is Familial prostate cancer.